Resmed Inc (RMD)
NYSE:RMD
Want to see RMD full AI Analyst Report?
RMD Stock Chart & Stats
$228.12
-$0.23(-0.10%)
At close: 4:00 PM EST
$228.12
-$0.23(-0.10%)
Day’s Range― - ―
52-Week Range$198.61 - $293.81
Previous CloseN/A
Volume178.41K
Average Volume (3M)1.29M
Market Cap
$29.61B
Enterprise Value$29.32B
Total Cash (Recent Filing)$1.66B
Total Debt (Recent Filing)$843.17M
Price to Earnings (P/E)20.6
Beta0.66
Next Earnings
Jul 30, 2026EPS Estimate
2.89Next Dividend Ex-DateN/A
Dividend Yield0.92%
Share Statistics
EPS (TTM)10.38
Shares Outstanding145,056,380
10 Day Avg. Volume1,313,851
30 Day Avg. Volume1,290,008
Financial Highlights & Ratios
PEG Ratio0.72
Price to Book (P/B)6.34
Price to Sales (P/S)7.36
P/FCF Ratio22.78
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue5.29
Enterprise Value/Gross Profit8.58
Enterprise Value/Ebitda13.95
Forecast
1Y Price Target
$264.56Price Target Upside15.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)11.11
Revenue Forecast (FY)$5.65B
Bulls Say, Bears Say
Bulls Say
Installed Base And Recurring RevenueExpansion of the installed base of cloud-connected devices increases recurring revenue from services and supplies, which can stabilize sales between device cycles.
International Growth And Market DiversificationAnalyst highlights stronger international device growth that diversifies revenue streams and reduces reliance on any single market, supporting long-term resilience.
Margin Expansion And Operational EfficiencyGross margin expansion driven by favorable product mix, lower component costs, and manufacturing efficiencies improves profitability and supports earnings upside.
Bears Say
Competitive Threat From Philips ReentryAnalyst warns that a Philips return to the U.S. flow-generator market could intensify price competition and force higher sales and marketing spending, pressuring margins.
Demand Risk From Weight-loss DrugsInvestor concern that GLP-1 and other weight-loss drugs could reduce demand for sleep-apnea equipment has contributed to valuation multiple compression and potential revenue downside.
Rising Operating Expenses And Tax ImpactHigher selling, general and administrative expenses and a higher effective tax rate have partially offset revenue and margin gains, limiting net earnings improvement.
Resmed News
RMD FAQ
What was Resmed Inc’s price range in the past 12 months?
Resmed Inc lowest stock price was $198.61 and its highest was $293.81 in the past 12 months.
What is Resmed Inc’s market cap?
Resmed Inc’s market cap is $29.61B.
When is Resmed Inc’s upcoming earnings report date?
Resmed Inc’s upcoming earnings report date is Jul 30, 2026 which is in 70 days.
How were Resmed Inc’s earnings last quarter?
Resmed Inc released its earnings results on Apr 30, 2026. The company reported $2.86 earnings per share for the quarter, beating the consensus estimate of $2.795 by $0.065.
Is Resmed Inc overvalued?
According to Wall Street analysts Resmed Inc’s price is currently Undervalued.
Does Resmed Inc pay dividends?
Resmed Inc pays a Quarterly dividend of $0.6 which represents an annual dividend yield of 0.92%. See more information on Resmed Inc dividends here
What is Resmed Inc’s EPS estimate?
Resmed Inc’s EPS estimate is 2.89.
How many shares outstanding does Resmed Inc have?
Resmed Inc has 145,056,380 shares outstanding.
What happened to Resmed Inc’s price movement after its last earnings report?
Resmed Inc reported an EPS of $2.86 in its last earnings report, beating expectations of $2.795. Following the earnings report the stock price went down -4.111%.
Which hedge fund is a major shareholder of Resmed Inc?
Currently, no hedge funds are holding shares in RMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Resmed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$264.56 (15.97% Upside)
$264.56 (15.97% Upside)
Blogger Sentiment
Bullish
RMD Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 32.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days >0.1%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.18%
12-Months-Change
Fundamentals
Return on Equity
24.41%
Trailing 12-Months
Asset Growth
16.09%
Trailing 12-Months
Company Description
Resmed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
RMD Company Deck
RMD Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a broadly positive operational and financial picture: durable revenue growth (11% headline, 8% constant), material gross margin expansion (+290 bps YoY), double‑digit EPS growth (~21%), strong free cash flow and capital returns, successful product rollouts (fabric masks, AirSense 11) and large real‑world evidence supporting a GLP‑1 demand tailwind. Management acknowledged and is actively managing a set of medium‑term headwinds — including rising SG&A and R&D investments, isolated investment write‑downs, RCS vertical challenges, component cost pressures, and near‑term acquisition dilution — but positioned these as manageable given a strong balance sheet, ongoing supply chain productivity initiatives, and targeted M&A.View all RMD earnings summariesRMD Revenue Breakdown
51.79% Devices
35.75% Masks and other
12.46% Software as a Service
RMD Stock 12 Month Forecast
Average Price Target
$264.56
▲(15.97% Upside)
Technical Analysis
Ownership Overview
0.53% Insiders
16.88% Mutual Funds
11.11% Other Institutional Investors
44.68% Public Companies and Individual Investors